Although most of patients with
non-insulin-dependent diabetes mellitus (
NIDDM) have
insulin resistance, it is unknown whether a molecule might interfere with
insulin action.
Membrane glycoprotein PC-1 (plasma cell
antigen-1), which inhibits
insulin receptor tyrosine kinase activity, was isolated from fibroblasts of
NIDDM patients. Because PC-1 content in skeletal muscle and adipose tissue correlated with whole body
insulin sensitivity, PC-1 might play a role in
insulin resistance. In order to know whether PC-1 activity of fibroblasts is also elevated in Japanese
NIDDM patients, and whether PC-1 activity correlates with the parameters of
insulin resistance in vivo or not, we measured PC-1 activity of cultured fibroblasts from 17 patients with
NIDDM and seven healthy controls. PC-1 activity of the
NIDDM patients was 85.2 +/- 33.1 nmol/mg per min (mean +/- S.D.), and was higher than that of healthy controls (42.6 +/- 12.7 nmol/mg per min, P = 0.0002).
Insulin sensitivity was measured in 11 of 17
NIDDM patients by the
artificial pancreas. PC-1 activity of the patients with
insulin resistance (
glucose infusion rate < 3.0 mg/kg per min, n = 7) was elevated to 99.9 +/- 31.9 nmol/mg per min, while that of the other patients (n = 4) was 55.3 +/- 7.5 nmol/mg per min (P = 0.003). In conclusion,
glycoprotein PC-1 activity of dermal fibroblasts is correlated with
insulin resistance in patients with
NIDDM.